ENDONOVO THERAPEUTICS, INC. Finite-Lived Patents, Gross
ENDONOVO THERAPEUTICS, INC. (ENDV) had Finite-Lived Patents, Gross of $4.50 million as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2023-12-29
- 2023-09-30: Finite-Lived Patents, Gross $4.50M.
- 2023-06-30: Finite-Lived Patents, Gross $4.50M.
- 2023-03-31: Finite-Lived Patents, Gross $4.50M.
- 2022-12-31: Finite-Lived Patents, Gross $4.50M.
| Period end | Finite-Lived Patents, Gross |
|---|---|
| 2023-09-30 | $4.50M 10-Q · filed 2023-12-29 |
| 2023-06-30 | $4.50M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $4.50M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $4.50M 10-Q · filed 2023-12-29 |
| 2022-09-30 | $4.50M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $4.50M 10-Q · filed 2022-08-22 |
| 2022-03-31 | $4.50M 10-Q · filed 2022-05-19 |
| 2021-12-31 | $4.50M 10-K · filed 2023-04-17 |
| 2021-09-30 | $4.50M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $4.50M 10-Q · filed 2021-08-23 |
| 2021-03-31 | $4.50M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $4.50M 10-K · filed 2022-04-14 |
| 2020-09-30 | $4.50M 10-Q · filed 2020-11-19 |
| 2020-06-30 | $4.50M 10-Q · filed 2020-08-19 |
| 2020-03-31 | $4.50M 10-Q · filed 2020-06-12 |
| 2019-12-31 | $4.50M 10-K · filed 2021-04-13 |
| 2019-09-30 | $4.50M 10-Q · filed 2019-11-19 |
| 2018-12-31 | $4.50M 10-K · filed 2020-05-04 |